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A membrane preparation from porcine cerebellum displays high-affinity binding sites for PH]inositol 1,3,4,5_tetrakis- 
phosphate (PH]InsP,) with a dissociation constant (&) of 1.0 nM and a density of 220 fmol/mg protein. Specific binding 
was maximal in the presence of 25 mM phosphate and at pH 5.0. The receptor site was specific for InsP,, since 
Ins(1,3,4,5,6)P, and Ins(1,4,5,6)P, displaced binding of InsP., with EC,, values of 0.2 and 0.3 PM, respectively. 
Ins(1,4,5)P, and other inositol phosphates were less effective. Using this InsP, receptor, an assay for measuring tissue 
content of InsP, was developed. The detection limit of the assay was 0.1 pmol. In the same tissue samples the amount 
of Ins(1,4,5)P, was determined in parallel with a similar assay using a binding protein preparation from beef liver. 
Inositol 1,3,4,5_tetrakisphosphate; Inositol 1,4,5trisphosphate; Receptor, inositol phosphate; Bradykinin 
1. INTRODUCTION 
In a large variety of cells, cellular signal trans- 
duction involves activation of phosphoinositide- 
specific phospholipase C [l] yielding the second 
messengers Ins(1,4,5)Ps and diacylglycerol. InsP3, 
which releases Ca’+ from the endoplasmatic 
reticulum [l], is rapidly phosphorylated to yield 
Ins(1,3,4,5)P4 [2]. InsP4 has been proposed to 
mediate receptor-activated Ca2+ influx from the 
extracellular environment [3] and to regulate cyto- 
solic Ca2+ activity by promoting replenishment of 
intracellular Ca2+ stores either from the extra- 
cellular space [4] or from the cytosol [5]. 
The concentrations of two prominent inositol 
phosphates, InsP3 and InsP4, in tissue extracts 
must be determined in order to establish the activa- 
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tion of inositol phosphate metabolism by hor- 
mones. In most cases, the various inositol phos- 
phates are quantitated by HPLC analysis of the in- 
ositol phosphate metabolites from cells prelabelled 
with [3H]inositol. A receptor assay for Ins(l,4,5)P3 
has recently been reported [6-S], which greatly 
facilitates the measurement of InsP3. Here, we 
report the development of a novel, specific recep- 
tor protein assay for InsP4. Furthermore, we use a 
binding protein for InsP3 that is more readily avail- 
able than that employed in current procedures for 
InsP3 assay [6,8]. Thus, in the same tissue sample 
both InsP3 and InsP4 can be measured without fur- 
ther purification. 
2. MATERIALS AND METHODS 
[3H]Ins(1,3,4,5)P4 (spec. act. 50-52 Ci/mmol) and 
[3H]Ins(l,4,5)Ps (spec. act. 42-50 Ci/mmol) were from Amer- 
sham (Braunschweig); Ins(1,3,4,5)P+ Ins(1,3,4)Pr and 
Ins(1,4,5)P, (as the potassium salts), were from Calbiochem 
(Frankfurt); Iris(l)))) Ins(4,5)P2, Ins(l,4)Pz, Ins(1,4,5)Pr, 
Ins(2,4,5)Ps, Ins(1,3,4,5)P4, Ins(1,4,5,6)P4, Ins(1,3,4,5,6)Ps (as 
the ammonium salts) and adenosine and guanosine 5’-triphos- 
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phates were from Boehringer (Marmheim); phytic acid 
[Ins(1,2,3,4,5,6)Ps] and heparin being obtained from Sigma 
(Taufkirchen). 
Binding protein for Ins(1,3,4,5)P4 was prepared from freshly 
collected pig cerebellum. The tissue was homogenized in 10 vols 
buffer containing (mM) Tris-HCl (50), EDTA (l), mercapto- 
ethanol (l), pH 7.7, 4°C. The homogenate was centrifuged for 
30 min at 35 000 x g, the pellet resuspended and homogenized 
again, centrifuged (30 min, 35 000 x g), washed with buffer and 
centrifuged. The final pellet, resuspended in buffer at a concen- 
tration of IO-20 mg/ml, was homogenized using a Potter- 
Elvejhem and kept at -20°C. A similar procedure was applied 
to obtain the binding protein for Ins(1,4,5)P3 from fresh beef 
liver. 
For radioligand-binding studies, binding protein from 
cerebellum (0.3-1.0 mg per test tube) was added to a solution 
containing (final concentrations in mM), EDTA (l), bovine 
serum albumin (2.5 mg/ml), sodium acetate (25) and potassium 
phosphate (25), pH 5.0, [3H]Ins(l ,3,4,5)P4 (approx. 10000 dpm 
= 84 fmol) as tracer to give a final concentration of 0.22 nM 
and, where indicated, unlabelled Ins(l,3,4,5)P4, tissue sample 
or other reagents. Incubations were carried out on ice. A solu- 
tion of sucrose (5%), sodium acetate (25 mM), pH 5.0, was 
carefully injected into the reaction vial to obtain a sucrose densi- 
ty gradient with the reaction mixture (400 ~1) forming the upper 
phase. After 20 min the reaction vials were centrifuged 
(10000 x g) in a cooled Heraeus biofuge A for 3 min, thus 
separating the membranes from unbound ligand. This separa- 
tion of bound from unbound ligand through a gradient improv- 
ed the reproducibility. Thus, deviations of duplicate incubations 
were maximally 4% from the mean. The mean deviation for all 
samples used for 6 calibration curves (cf. fig.lA) was 2.5%. 
Finally, the pellet containing the bound label was quantitatively 
transferred to 5-ml scintillation vials by centrifugation for 5 min 
at 1500 x g and 3.5 ml scintillation liquid (Rotiszint 22, Roth, 
Karlsruhe) were added. Quenching was taken into account by 
automatic correction with a quench standard curve (LKB, 1214 
Rack-beta) giving the final results in dpm. Ins(1,4,5)P3 was 
determined similarly except hat the reaction mixture contained 
(mM) EDTA (l), Tris-HCl(25), pH 9.0, bovine serum albumin 
(1 mg/ml). The binding reaction was initiated by adding binding 
protein isolated from bovine liver. 
For the experiments neuroblastoma x glioma hybrid cells 
were cultured as described [9]. Cells were preincubated for 10 or 
20 min in incubation medium [ 101. After the challenge incuba- 
tion with bradykinin the medium was aspirated, 1 ml ice-cold 
trichloroacetic acid (10010) was added, the mixture kept on ice 
for more than 20 min and then centrifuged (2 min, 5000 x g). 
The supernatant was extracted 4 times with 2 vols diethyl ether. 
In the samples, which had been neutralized with the appropriate 
volume of 1 M NaHCOs, the content of InsP4 and InsP3 was 
determined. 
3. RESULTS 
InsP4 binds with high affinity to a receptor in 
membranes from pig cerebellum. Specific binding 
of tracer is reduced by 50% in the presence of 
1.8 nM InsP4 and by 90% at concentrations above 
156 
25 nM (fig.lA). Scatchard analysis of 
[3H]Ins(l,3,4,5)P4-binding data (fig.lA, inset) 
revealed a high-affinity binding site with a dissocia- 
tion constant (&) of 1.0 -t 0.3 nM (n = 7) and a 
binding capacity (Bmax) of 220 + 50 fmol/mg pro- 
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Fig.1. (A) Specific binding of [‘H]InsPd [0.2 nM (o)] and 
[‘H]InsPs [0.26 nM (A)], respectively, as a function of increas- 
ing concentration of unlabelled ligand using binding protein 
from cerebellum (0) or from liver (A). Maximal specific bind- 
ing (Bo) was 2060 dpm for (0) and 1170 dpm for (A); reaction 
volume 400 ~1. Unspecific binding, in the presence of 1 CM un- 
labelled ligand, was 34% (for InsP4) and 14% (for InsP3) of 
total maximal binding. (Inset) Scatchard analysis of binding 
data for high-affinity binding of InsP4 from another experi- 
ment. Concentration of [‘H]InsP.+: 0.18 nM, 0.3 mg protein per 
assay. Specifically bound ligand was obtained by correcting for 
unspecific binding in the presence of 1 pM unlabelled InsP4. (B) 
Kinetics of association and dissociation of [“H]InsPA with 
binding sites from cerebellum (100%: binding at 20 min). 
Binding was initiated by adding the binding protein to an assay 
mixture containing 0.18 nM [3H]InsP4 kept at 0°C. Dissocia- 
tion was started by adding 1 /rM InsP4 at the time point in- 
dicated by an arrow. /for&,, gave a Kd value of 1.1 + 0.4 nM 
(n = 3). Incubations were terminated by immediate centrifuga- 
tion through a sucrose density gradient (see section 2). Here and 
in fig.2, data points give the means of duplicate incubations. 
Similar results were obtained in 3 and 2 further experiments for 
A and B, respectively. 
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tein. A second low-affinity site with a & of about 
100 nM was not characterized further. 
Some of the properties of the high-affinity 
InsP4-binding site were determined to optimize the 
conditions for binding. On varying the pH between 
3 and 8, a 4-fold increase in specific binding was 
obtained at pH 5.0 (not shown). Specific binding of 
InsP3, however, is maximal at pH 8.0-9.0 for the 
receptor from parathyroid [l l] and from liver (not 
shown). Variation in the Ca2+ concentration from 
10 nM to 10 mM did not alter binding of InsP4 by 
more than 20%. However, when the concentration 
of phosphate was varied from 1 to 100 mM a clear 
maximum of specific binding of [3H]InsP4 was ob- 
tained at around 25 mM (not shown). 
Analysis of the kinetics showed that specific 
binding of InsPA was half-maximal within 140 s 
and remained constant between 10 and 30 min 
after addition of ligand (fig.lB). Addition of 1 PM 
unlabelled InsP4 caused displacement of bound 
ligand with a half-time for dissociation of 165 s. 
The specificity of the InsPd-binding site was 
determined in competition binding experiments 
performed with several inositol phosphates (fig.2). 
Among the compounds tested, the pentakisphos- 
phate Ins(1,3,4,5,6)P5 had the highest interfering 
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Fig.2. Specificity of InsI’d binding to porcine cerebellar mem- 
branes. Displacement of [3H]InsP4 binding by various inositol 
phosphates, ATP, GTP and inositol. Specific binding, relative 
to Bs (1690 dpm) of 0.18 nM [‘H]InsP4 in the presence of 
various concentrations of Ins(1,3,4,5)P4 (o), Ins(1,3,4,5,6)Ps 
(A), Ins(1,4,5,6)Pd (v), Ins(1,3,4)Pr (m), phytic acid 
(Ins(l,2,3,4,5,6)Ps) (O), Ins(1,4,5)P3 (v), Ins(2,4,5)P3 (a). 
GTP (o), ATP (A) and inositol (0), corrected for unspecific 
binding in the presence of 1 PM unlabelled Ins(1,3,4,5)Pb. 
Deviations (mean error 1.9%, max. 5%) were omitted for clari- 
ty. Comparable results were obtained for the various inhibitors 
in 2 or 3 further experiments. 
affinity, but the EC50 of about 0.2 PM was 2 orders 
of magnitude greater than that of Ins(1,3,4,5)P4. 
Ins(1,4,5,6)P4 had an EC50 of 0.3 /cM. However, 
the supplier of Ins(l,4,5,6)P4 indicates that the 
substance contains 12% Ins(2,4,5,6)Pd and a fur- 
ther contamination with less than 0.5% 
Ins(1,3,4,5)P4 would suffice to account for the in- 
hibition observed here. The inositol trisphosphates 
tested had a very low activity in comparison with 
Ins(1,3,4,5)P4 with EC50 values of 0.4 PM for 
Ins(1,3,4)P3, 6/cM for Ins(1,4,5)P3 and above 
10pM for Ins(2,4,5)P3. Ins(l)P, Ins(4,5)P2 and 
Ins(1,4)P2 did not affect specific binding of 
Ins(l,3,4,5)P4 even at 10 PM (not shown). An im- 
portant requirement concerning a suitable test 
system for InsP4 is the ability to discriminate clear- 
ly between Ins(1,3,4,5)P4 and Ins(1,4,5)P3, whose 
synthesis is stimulated considerably by many hor- 
mones [l]. Both of the nucleotides ATP and GTP 
reduced specific binding at 60 to 80 PM by 50% 
(fig.2). Heparin caused 50% displacement at about 
25 pg/ml (not shown). 
A neuronal cell line in which bradykinin has been 
shown to induce rapid phosphatidylinositol 
response [12] was taken as proof of the applicabili- 
ty of our test assay system. The basal level of 
2.7 pmol/mg protein InsP4 was close to the detec- 
tion limit. In the presence of 2 PM bradykinin, 
InsP4 increased to a nearly constant level of 
25.9 pmol/mg protein between 20 and 60 s after 
adding the peptide. In the same cells, InsP3 rose 
transiently from 5.9 to maximally 145 pmol/mg 
protein at 15-20 s after addition of bradykinin, 
declining sharply thereafter. The InsP4 assay was 
shown to be linear by testing different volumes 
from the same samples (not shown). 
4. DISCUSSION 
In porcine cerebellum membranes, there is a 
population of receptors which rapidly and rever- 
sibly bind InsP4 with an apparent dissociation con- 
stant of 1.0 nM. Binding sites for InsP4 have been 
described previously for HL-60 cells [13] and 
various rat tissues [14]. However, the receptors 
detected had a much lower affinity (& 90 and 
300 nM, respectively). Moreover, the receptor 
from rat tissue did not really discriminate between 
InsP4 and InsP3 [14]. The receptor for InsP4 
characterized here, which shows similarities with 
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the InsP4-binding site in bovine parathyroid glands affinity (& 4.8 k 0.9 nM, &,, 440 + 70 fmol/mg 
[ 111, opens up the possibility of investigating the protein, n = 4) and comparable selectivity among 
still elusive biological function of InsP4 in the inositol phosphates and was stable during radio- 
signal transduction mechanism. receptor assays for at least 3 months (not shown). 
With optimal conditions for InsP4 binding, the 
receptor preparation from porcine cerebellum is 
suitable for measuring InsP4 by radioligand dis- 
placement, since there is strong selectivity for 
Ins(l,3,4,5)P4. The conditions used for the binding 
studies (O’C, addition of 1 mM EDTA in the 
absence of Mg*+) were designed to reduce any 
residual phosphatase activity which could degrade 
the label. The lower limit of sensitivity of the assay 
is about 0.1 pmol InsP4 per sample of 400 ~1. 
Thus, a significant component of the inositol phos- 
phate response can be easily measured, which was 
hitherto detectable only after separation of the in- 
ositol phosphates by anion-exchange 
chromatography using mostly a HPLC system [2]. 
However, this technique requires prelabelling of 
the inositol lipid pool in the cells with a radioactive 
tracer, which is only possible for tissues which can 
be maintained in culture. Mass measurements of 
InsP, [ 15,161 involving prior separation by HPLC 
followed by analysis on various detection systems 
are laborious and not applicable for routine tests of 
multiple samples. The radioreceptor assay describ- 
ed here provides the opportunity to quantitate 
InsP4 in tissue extracts easily and directly. 
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